Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 2/20 | 0.62 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.56 |
| ▸ | GUSB | P08236 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5936672 | 0.94 | SMPD1 (0.60) | SMPD1NR1H4MEN1KMT2ANR4A2 | |
| SCHEMBL5936638 | 0.82 | NR1H4 (0.69) | SMPD1NR1H4MEN1KMT2ANR4A2 | |
| SCHEMBL1123450 | 0.80 | SMPD1 (0.59) | SMPD1NR1H4MEN1KMT2ANR4A2 | |
| SCHEMBL13702365 | 0.79 | SMPD1 (0.76) | SMPD1NR1H4MEN1KMT2ANR4A2 | |
| SCHEMBL1122980 | 0.77 | NR1H4 (0.56) | SMPD1NR1H4MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7410475 | 0.77 | SMPD1 (0.78) | SMPD1NR1H4MEN1KMT2ANR4A2 | |
| SCHEMBL1608032 | 0.77 | SMPD1 (1.00) | SMPD1NR1H4MEN1KMT2ANR4A2 | |
| SCHEMBL5936675 | 0.77 | NR1H4 (0.67) | SMPD1NR1H4MEN1KMT2AGUSB | |
| SCHEMBL27966079 | 0.77 | NR1H4 (0.71) | SMPD1NR1H4MEN1KMT2ANR4A2 | |
| SCHEMBL1122713 | 0.77 | NR4A2 (0.94) | SMPD1NR1H4MEN1KMT2ANR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | SMPD1 1734/4885NR1H4 160/4885MEN1 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.